Invasive Endocervical Adenocarcinoma
- 1 November 2013
- journal article
- pathology of-the-lower-genital-tract
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 32 (6) , 592-601
Abstract
The management of endocervical adenocarcinoma is largely based on tumor size and depth of invasion (DOI); however, DOI is difficult to measure accurately. The surgical treatment includes resection of regional lymph nodes, even though most lymph nodes are negative and lymphadenectomies can cause significant morbidity. We have investigated alternative parameters to better identify patients at risk of node metastases. Cases of invasive endocervical adenocarcinoma from 12 institutions were reviewed, and clinical/pathologic features assessed: patients’ age, tumor size, DOI, differentiation, lymph-vascular invasion, lymph node metastases, recurrences, and stage. Cases were classified according to a new pattern-based system into Pattern A (well-demarcated glands), B (early destructive stromal invasion arising from well-demarcated glands), and C (diffuse destructive invasion). In total, 352 cases (FIGO Stages I–IV) were identified. Patients’ age ranged from 20 to 83 years (mean 45), DOI ranged from 0.2 to 27 mm (mean 6.73), and lymph-vascular invasion was present in 141 cases. Forty-nine (13.9%) demonstrated lymph node metastases. Using this new system, 73 patients (20.7%) with Pattern A tumors (all Stage I) were identified. None had lymph node metastases and/or recurrences. Ninety patients (25.6%) had Pattern B tumors, of which 4 (4.4%) had positive nodes; whereas 189 (53.7%) had Pattern C tumors, of which 45 (23.8%) had metastatic nodes. The proposed classification system can spare 20.7% of patients (Pattern A) of unnecessary lymphadenectomy. Patients with Pattern B rarely present with positive nodes. An aggressive approach is justified in patients with Pattern C. This classification system is simple, easy to apply, and clinically significant.Keywords
This publication has 10 references indexed in Scilit:
- Incidence and Risk Factors of Lower-Extremity Lymphedema After Radical Surgery With or Without Adjuvant Radiotherapy in Patients With FIGO Stage I to Stage IIA Cervical CancerInternational Journal of Gynecological Cancer, 2012
- Conservative Therapy in Microinvasive Adenocarcinoma of the Uterine Cervix is JustifiedInternational Journal of Gynecological Cancer, 2011
- Recent Developments in Defining Microinvasive and Early Invasive Carcinoma of the Uterine CervixJournal of Lower Genital Tract Disease, 2011
- Revised FIGO staging for carcinoma of the cervixInternational Journal of Gynecology & Obstetrics, 2009
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometriumInternational Journal of Gynecology & Obstetrics, 2009
- Microinvasive Cervical Adenocarcinoma (FIGO Stage 1A Tumors)American Journal of Surgical Pathology, 2006
- Symposium Part I: Adenocarcinoma In Situ, Glandular Dysplasia, and Early Invasive Adenocarcinoma of the Uterine CervixInternational Journal of Gynecological Pathology, 2002
- Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervixCurrent Opinion in Oncology, 2001
- Early Invasive Adenocarcinoma of the Uterine CervixInternational Journal of Gynecological Pathology, 2000
- Modifications in the staging for Stage I vulvar and Stage I cervical cancerInternational Journal of Gynecology & Obstetrics, 1995